G01N 2333/90
Enzymes
Official title: Enzymes; Proenzymes
G01N2333/90 (Enzymes) appears on 6,400 US grants and 10,664 published applications in this corpus.
Search patents in G01N- Granted patents
- 6,400
- Published applications
- 10,664
- Assignees
- 4,022
- Inventors
- 21,141
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 12 | 0 |
| 1978 | 8 | 0 |
| 1979 | 11 | 0 |
| 1980 | 11 | 0 |
| 1981 | 15 | 0 |
| 1982 | 16 | 0 |
| 1983 | 17 | 0 |
| 1984 | 15 | 0 |
| 1985 | 12 | 0 |
| 1986 | 14 | 0 |
| 1987 | 20 | 0 |
| 1988 | 17 | 0 |
| 1989 | 18 | 0 |
| 1990 | 16 | 0 |
| 1991 | 16 | 0 |
| 1992 | 37 | 0 |
| 1993 | 46 | 0 |
| 1994 | 47 | 0 |
| 1995 | 44 | 0 |
| 1996 | 53 | 0 |
| 1997 | 77 | 0 |
| 1998 | 140 | 0 |
| 1999 | 132 | 0 |
| 2000 | 127 | 0 |
| 2001 | 124 | 45 |
| 2002 | 120 | 207 |
| 2003 | 109 | 349 |
| 2004 | 113 | 260 |
| 2005 | 88 | 292 |
| 2006 | 129 | 298 |
| 2007 | 114 | 297 |
| 2008 | 114 | 287 |
| 2009 | 118 | 378 |
| 2010 | 174 | 461 |
| 2011 | 162 | 399 |
| 2012 | 210 | 441 |
| 2013 | 217 | 410 |
| 2014 | 279 | 465 |
| 2015 | 327 | 755 |
| 2016 | 347 | 775 |
| 2017 | 358 | 627 |
| 2018 | 362 | 476 |
| 2019 | 367 | 458 |
| 2020 | 375 | 450 |
| 2021 | 262 | 450 |
| 2022 | 228 | 386 |
| 2023 | 189 | 380 |
| 2024 | 214 | 488 |
| 2025 | 210 | 482 |
| 2026 | 162 | 348 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2333/914HydrolasesIndexing code3,412
- G01N 2333/91TransferasesIndexing code1,790
- G01N 2333/902OxidoreductasesIndexing code1,077
- G01N 2333/988LyasesIndexing code210
- G01N 2333/9015LigasesIndexing code203
- G01N 2333/99IsomerasesIndexing code132
- G01N 2333/901Antibodies with enzymatic activityIndexing code12
- G01N 2333/9005Enzymes with nucleic acid structureIndexing code9
All 9 subgroupsShow fewer
Recent patents
- Molecular profiling of tumors6 Oct 2026US 12,754,193 B2Caris MPI, Inc.
- Modulating human Cas9-specific host immune response29 Sep 2026US 12,747,432 B2Arizona Board of Regents on behalf of Arizona State University
- Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors29 Sep 2026US 12,748,111 B2The Scripps Research Institute
- Diagnosis, prognosis and treatment of malignant neoplasms29 Sep 2026US 12,748,114 B2Rhode Island Hospital
- Method for producing an exdotoxin measuring agent29 Sep 2026US 12,748,115 B2Seikagaku Corporation
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Anti-cancer treatments and methods of use thereof8 Oct 2026US 2026/0308535 A1
- Assay for Rapid Detection of Antibiotic Resistant Organisms8 Oct 2026US 2026/0308658 A1Queen's University at Kingston
- Analyte sensors and sensing methods for detecting creatinine8 Oct 2026US 2026/0309669 A1Abbott Diabetes Care Inc.
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
Most cited
By later US patents
- Method of using a small volume in vitro analyte sensor1,793US 6,120,676 ATheraSense, Inc. · 2000
- Small volume in vitro analyte sensor1,656US 6,143,164 AE. Heller & Company · 2000
- Small volume in vitro analyte sensor1,028US 6,551,494 B1TheraSense, Inc. · 2003
- Small volume in vitro analyte sensor1,023US 6,576,101 B1TheraSense, Inc. · 2003
- Biosensor and a method for measuring a concentration of a substrate in a sample903US 5,264,103 AMatsushita Electric Industrial Co., Ltd. · 1993